Format

Send to

Choose Destination
Yale J Biol Med. 2016 Sep 30;89(3):383-388. eCollection 2016 Sep.

Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation.

Author information

1
Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, CA.
2
Division of Gastroenterology, University of California, San Diego, La Jolla, CA.

Abstract

The worldwide prevalence of metabolic syndrome, which includes obesity and its associated diseases, is rising rapidly. The human gut microbiome is recognized as an independent environmental modulator of host metabolic health and disease. Research in animal models has demonstrated that the gut microbiome has the functional capacity to induce or relieve metabolic syndrome. One way to modify the human gut microbiome is by transplanting fecal matter, which contains an abundance of live microorganisms, from a healthy individual to a diseased one in the hopes of alleviating illness. Here we review recent evidence suggesting efficacy of fecal microbiota transplant (FMT) in animal models and humans for the treatment of obesity and its associated metabolic disorders.

KEYWORDS:

Fecal microbiota transplant; metabolic syndrome; obesity

PMID:
27698622
PMCID:
PMC5045147
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center